Valsts: Grieķija
Valoda: angļu
Klimata pārmaiņas: HMA (Heads of Medicines Agencies)
lincomycin 400 mg/g
Lavet Pharmaceuticals Ltd.
QJ01FF02
Powder for oral solution
lincomycin
Chicken, Pigs
2010-11-24
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Linco-Sol 400 mg/g powder for use in drinking water for pigs and chickens 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Lincomycin (as hydrochloride) 400 mg/g EXCIPIENTS: For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Powder for use in drinking water. White or almost white powder. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Swine and chicken (broiler) 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of infection caused by mycoplasma and bacteria_ _susceptible to lincomycin for example: Pigs: swine dysentery caused by _Brachyspira hyodysenteriae_ and mycoplasma pneumonia associated with _Mycoplasma hyopneumoniae_. Chicken: necrotic enteritis caused by _Clostridium perfringens._ 4.3 CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substance or to the excipient. Do not use if resistance to lincosamides has been detected. Do not administer to horses, ruminants, guinea pigs, hamsters, chinchilla and rabbits. Ingestion by these species may result in severe gastrointestinal effects. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE _Special precautions for use in animals _ Medicated drinking water uptake can be affected by the severity of the disease. In case of insufficient uptake of water, animals should be treated parenterally. Use of the product should be based on susceptibility testing and take into account official and local antimicrobial policies. Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant t Izlasiet visu dokumentu